New P2Y(12) inhibitors
- PMID: 20048234
- DOI: 10.1161/CIRCULATIONAHA.109.853069
New P2Y(12) inhibitors
Similar articles
-
Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.Thromb Haemost. 2007 Mar;97(3):435-43. Thromb Haemost. 2007. PMID: 17334511
-
Platelet responsiveness to yohimbine hydrochloride and MRS2179 in the context of the interaction between collagen and epinephrine in acute coronary syndrome.Blood Cells Mol Dis. 2009 Jul-Aug;43(1):105-10. doi: 10.1016/j.bcmd.2009.02.002. Epub 2009 Mar 9. Blood Cells Mol Dis. 2009. PMID: 19272818
-
Clinical profile of prasugrel, a novel thienopyridine.Am Heart J. 2008 Aug;156(2 Suppl):S16-22. doi: 10.1016/j.ahj.2008.06.005. Am Heart J. 2008. PMID: 18657682 Review.
-
Is prasugrel more effective than clopidogrel in patients with acute coronary syndrome scheduled for PCI?Am Fam Physician. 2008 Dec 1;78(11):1252-3. Am Fam Physician. 2008. PMID: 19069017 Review. No abstract available.
-
Cangrelor: a novel P2Y12 receptor antagonist.Expert Opin Investig Drugs. 2009 Aug;18(8):1219-30. doi: 10.1517/13543780903136708. Expert Opin Investig Drugs. 2009. PMID: 19604122 Review.
Cited by
-
Pharmacological Approaches to Limit Ischemic and Reperfusion Injuries of the Heart: Analysis of Experimental and Clinical Data on P2Y12 Receptor Antagonists.Korean Circ J. 2022 Oct;52(10):737-754. doi: 10.4070/kcj.2022.0162. Korean Circ J. 2022. PMID: 36217596 Free PMC article. Review.
-
A transition of P2Y12 antagonists for acute coronary syndrome: benefits, risks and costs.J Thromb Thrombolysis. 2014;37(2):102-6. doi: 10.1007/s11239-013-0918-8. J Thromb Thrombolysis. 2014. PMID: 23584598 Review.
-
The Efficacy and Safety of Antiplatelet Therapy in Patients With Acute Coronary Syndrome: A Scoping Review.Cureus. 2023 Nov 29;15(11):e49631. doi: 10.7759/cureus.49631. eCollection 2023 Nov. Cureus. 2023. PMID: 38161809 Free PMC article.
-
The platelet P2Y(12) receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [(3)H]PSB-0413.Purinergic Signal. 2013 Mar;9(1):59-66. doi: 10.1007/s11302-012-9329-0. Epub 2012 Aug 15. Purinergic Signal. 2013. PMID: 22892887 Free PMC article.
-
P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.Purinergic Signal. 2012 Sep;8(3):609-19. doi: 10.1007/s11302-012-9303-x. Epub 2012 Apr 11. Purinergic Signal. 2012. PMID: 22528678 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical